The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Common Stockindirect: Spouse | +814 | $2.05 | $1,669 | 4,135 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Common Stockindirect: Immediate family member | +143 | $2.05 | $293 | 734 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Common Stockindirect: Immediate family member | +143 | $2.05 | $293 | 734 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Common Stockindirect: Immediate family member | +143 | $2.05 | $293 | 734 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Warrant (right to buy)derivative | -10,935 | $0.00 | $0 | 0 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Warrant (right to buy)derivativeindirect: Spouse | -814 | $0.00 | $0 | 0 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Warrant (right to buy)derivativeindirect: Immediate family member | -143 | $0.00 | $0 | 0 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Warrant (right to buy)derivativeindirect: Immediate family member | -143 | $0.00 | $0 | 0 | Jun 13, 2023 |
| May 25, 2023 | PLSE Pulse Biosciences, Inc. | Mitchell E. Levinson Chief Strategy Officer | XIn-the-money exercise Warrant (right to buy)derivativeindirect: Immediate family member | -143 | $0.00 | $0 | 0 | Jun 13, 2023 |
| Jun 12, 2023 | PLSE Pulse Biosciences, Inc. | Darrin Uecker Chief Technology Officer | XIn-the-money exercise Common Stock | +7,365 | $2.05 | $15k | 877,636 | Jun 13, 2023 |
| Jun 12, 2023 | PLSE Pulse Biosciences, Inc. | Darrin Uecker Chief Technology Officer | XIn-the-money exercise Warrant (right to buy)derivative | -7,365 | $0.00 | $0 | 0 | Jun 13, 2023 |
| Jun 8, 2023 | AZEK AZEK Co Inc. | Ontario Teachers Pension Plan Board director | XIn-the-money exercise Class A Common Stock, par value $0.001 per share | -1,050,000 | $24.36 | $26M | 6,275,990 | Jun 12, 2023 |
| Jun 8, 2023 | AZEK AZEK Co Inc. | Ontario Teachers Pension Plan Board director | XIn-the-money exercise Option (obligation to sell)derivative | -1,050,000 | - | - | 0 | Jun 12, 2023 |
| Jun 8, 2023 | AZEK AZEK Co Inc. | Ares Corporate Opportunities Fund IV, L.P. director | XIn-the-money exercise Class A Common Stock | -1,050,000 | $24.36 | $26M | 6,276,090 | Jun 12, 2023 |
| Jun 8, 2023 | AZEK AZEK Co Inc. | Ares Corporate Opportunities Fund IV, L.P. director | XIn-the-money exercise Option (obligation to sell)derivative | -1,050,000 | - | - | 0 | Jun 12, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Common Shares | +917 | - | - | 376,917 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Common Shares | +7,084 | - | - | 383,639 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Common Shares | +4,167 | - | - | 385,080 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Common Shares | +2,392 | - | - | 385,957 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Warrant to Purchase Common Sharesderivative | -917 | $0.00 | $0 | 0 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Warrant to Purchase Common Sharesderivative | -7,084 | $0.00 | $0 | 0 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Warrant to Purchase Common Sharesderivative | -4,167 | $0.00 | $0 | 0 | Jun 8, 2023 |
| May 17, 2023 | LBRA 1847 Holdings LLC | Ellery Roberts Chairman and CEO | XIn-the-money exercise Warrant to Purchase Common Sharesderivative | -2,392 | $0.00 | $0 | 0 | Jun 8, 2023 |
| Jun 6, 2023 | GNE Genie Energy Ltd. | Howard S Jonas director, owner | XIn-the-money exercise Class B Common Stock, par value $.01 per share | +1,048,218 | $4.77 | $5.0M | 1,518,696 | Jun 8, 2023 |
| Jun 6, 2023 | GNE Genie Energy Ltd. | Howard S Jonas director, owner | XIn-the-money exercise Warrant (right to buy)derivative | -1,048,218 | $0.00 | $0 | 0 | Jun 8, 2023 |
| Jun 7, 2023 | AMR Alpha Metallurgical Resources, Inc. | Michael Gorzynski director, other | XIn-the-money exercise Common Stock, $0.01 par value per shareindirect: By Percy Rockdale LLC | +4,309 | $44.97 | $194k | 787,097 | Jun 8, 2023 |
| Jun 7, 2023 | AMR Alpha Metallurgical Resources, Inc. | Michael Gorzynski director, other | XIn-the-money exercise Common Stock, $0.01 par value per shareindirect: By MG Capital Management, Ltd. | +102 | $44.97 | $4,587 | 1,691 | Jun 8, 2023 |
| Jun 6, 2023 | AMR Alpha Metallurgical Resources, Inc. | Michael Gorzynski director, other | XIn-the-money exercise Common Stock, $0.01 par value per shareindirect: By Spouse | +864 | $44.97 | $39k | 4,486 | Jun 8, 2023 |
| Jun 7, 2023 | AMR Alpha Metallurgical Resources, Inc. | Michael Gorzynski director, other | XIn-the-money exercise Series A Warrantderivativeindirect: By Percy Rockdale LLC | -3,591 | $0.00 | $0 | 573 | Jun 8, 2023 |
| Jun 7, 2023 | AMR Alpha Metallurgical Resources, Inc. | Michael Gorzynski director, other | XIn-the-money exercise Series A Warrantderivativeindirect: By MG Capital Management, Ltd. | -85 | $0.00 | $0 | 13 | Jun 8, 2023 |
| Jun 6, 2023 | AMR Alpha Metallurgical Resources, Inc. | Michael Gorzynski director, other | XIn-the-money exercise Series A Warrantderivativeindirect: By Spouse | -720 | $0.00 | $0 | 0 | Jun 8, 2023 |
| Jun 1, 2023 | LMB Limbach Holdings, Inc. | Gordon G Pratt director | XIn-the-money exercise Common Stockindirect: See Footnote | +100,000 | $15.00 | $1.5M | 298,280 | Jun 2, 2023 |
| Jun 1, 2023 | LMB Limbach Holdings, Inc. | Gordon G Pratt director | XIn-the-money exercise $15 Exercise Price Sponsor Warrantderivativeindirect: See Footnote | -100,000 | $0.00 | $0 | 0 | Jun 2, 2023 |
| May 24, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Class A Common Stock, $0.01 par value | +500 | $7.50 | $3,750 | 1,491,543 | May 26, 2023 |
| May 24, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Put Option (obligation to buy)derivative | -5 | $0.00 | $0 | 2,546 | May 26, 2023 |
| May 22, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Class A Common Stock, $0.01 par value | +12,900 | $7.50 | $97k | 1,472,243 | May 24, 2023 |
| May 23, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Class A Common Stock, $0.01 par value | +18,800 | $7.50 | $141k | 1,491,043 | May 24, 2023 |
| May 22, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Put Option (obligation to buy)derivative | -129 | $0.00 | $0 | 2,718 | May 24, 2023 |
| May 23, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Put Option (obligation to buy)derivative | -21 | $0.00 | $0 | 0 | May 24, 2023 |
| May 23, 2023 | NDLS NOODLES & Co | Thomas E Lynch director, owner | XIn-the-money exercise Put Option (obligation to buy)derivative | -167 | $0.00 | $0 | 2,551 | May 24, 2023 |
| May 22, 2023 | TCRR TCR2 THERAPEUTICS INC. | Mpm Asset Management LLC owner | XIn-the-money exercise Common Stock | +178,269 | $0.74 | $132k | 374,171 | May 24, 2023 |
| May 22, 2023 | TCRR TCR2 THERAPEUTICS INC. | Mpm Asset Management LLC owner | XIn-the-money exercise Common Stock Warrant (Right To Buy)derivative | -42,761 | $0.00 | $0 | 0 | May 24, 2023 |
| May 22, 2023 | TCRR TCR2 THERAPEUTICS INC. | Mpm Asset Management LLC owner | XIn-the-money exercise Common Stock Warrant (Right to Buy)derivative | -135,508 | $0.00 | $0 | 0 | May 24, 2023 |
| May 22, 2023 | TCRR TCR2 THERAPEUTICS INC. | Ansbert Gadicke director, owner | XIn-the-money exercise Common Stockindirect: See Footnote | +178,269 | $0.74 | $132k | 374,171 | May 24, 2023 |
| May 22, 2023 | TCRR TCR2 THERAPEUTICS INC. | Ansbert Gadicke director, owner | XIn-the-money exercise Common Stock Warrant (Right To Buy)derivativeindirect: See Footnote | -42,761 | $0.00 | $0 | 0 | May 24, 2023 |
| May 22, 2023 | TCRR TCR2 THERAPEUTICS INC. | Ansbert Gadicke director, owner | XIn-the-money exercise Common Stock Warrant (Right to Buy)derivativeindirect: See Footnote | -135,508 | $0.00 | $0 | 0 | May 24, 2023 |
| Sep 22, 2020 | AP AMPCO PITTSBURGH CORP | Carl H Pforzheimer II director | XIn-the-money exercise Common Stockindirect: See Footnote | +714 | $3.50 | $2,499 | 2,314 | May 24, 2023 |
| Sep 22, 2020 | AP AMPCO PITTSBURGH CORP | Carl H Pforzheimer II director | XIn-the-money exercise Subscription Rights (right to buy)derivativeindirect: See Footnote | -1,600 | $0.00 | $0 | 0 | May 24, 2023 |
| Sep 22, 2020 | AP AMPCO PITTSBURGH CORP | Carl H Pforzheimer II director | XIn-the-money exercise Series A Warrant (right to buy)derivativeindirect: See Footnote | +1,600 | - | - | 1,600 | May 24, 2023 |
| May 18, 2023 | OLOX SAFE & GREEN HOLDINGS CORP. | John William Shaw owner | XIn-the-money exercise Common Stock | +22,100 | $1.00 | $22k | 4,454,600 | May 22, 2023 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.